New drugs for cardiac amyloidosis provide hope for patients
July 31, 2019
Medical Director, Internal Medicine Clinical Trials Unit
New Patient Appointment Accepting Virtual Visits or 214-645-5505
Justin Grodin, M.D., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center, and a member of its Division of Cardiology. His clinical interests include end-stage heart failure, restrictive cardiomyopathies, hereditary cardiomyopathies, and hypertropic cardiomyopathies.
Originally from El Paso, Texas, Dr. Grodin holds a bachelor's degree in chemistry from the University of Texas at Austin. He earned his medical degree at UT Southwestern, where he also completed internal medicine residency training. He performed two fellowships at the Cleveland Clinic, one in cardiovascular disease and one in advanced heart failure and transplant cardiology. Dr. Grodin also holds a master’s degree in public health from Harvard University in Cambridge, Massachusetts.
Certified by the American Board of Internal Medicine in cardiovascular disease, advanced heart failure and transplant cardiology, and by the National Board of Echocardiography, he joined the UT Southwestern faculty in 2016.
Dr. Grodin's research interests include heart failure, the treatment of acute heart failure, cardiorenal syndrome, and metabolic and hemodynamic biomarkers of heart failure.
Dr. Grodin has numerous peer-reviewed publications in scientific journals. He serves as Co-Section Editor for the Current Heart Failure Reports’ “Biomarkers of Heart Failure” and as an ad-hoc reviewer for the Journal of Cardiac Failure, the Journal of the American College of Cardiology, the American Heart Journal, Circulation: Heart Failure, and reviews abstracts for the American College of Cardiology.
He is a member of the American College of Cardiology, the Heart Failure Society of America, and the Texas Medical Association.
Justin Grodin, M.D., has specialty training in caring for people who are living with end-stage congestive heart failure. And he emphasizes the focus on living.
Dr. Grodin says, “I take a lot of pride in helping my patients understand their diagnosis, and in reassuring them that even though heart failure is serious, we’re going to make sure they’re getting the most thorough evaluation and best, individualized treatment.”
In severe cases, the treatment of advanced heart failure may require a heart transplant or a left ventricular assist device (LVAD), but Dr. Grodin says that medications and modifications in diet and lifestyle may be effective in delaying or even preventing major surgical interventions.
“For a portion of patients, the use of routine heart failure medications can actually improve cardiac function over time. In addition, there are novel disease-specific medications which may also treat specific heart conditions," Dr. Grodin says. Other patients benefit from minor surgical options, such as implantable defibrillators or pacemakers that resynchronize the heart.
In every case, Dr. Grodin takes his patients through a comprehensive evaluation to identify the best treatment approach. For people who need a transplant or an LVAD, Dr. Grodin walks them through the entire process, from the initial evaluation to the hospital and ICU, and then he continues to see them for follow-up care after surgery.
Dr. Grodin has a master’s degree in public health and specializes in clinical epidemiology. He leads research to improve our understanding of heart failure and to identify better treatments.
“Treatment for heart failure is continually evolving and we are constantly identifying clinical features which better our understanding of patient risk and may lead to individualized therapy,” he says.
The incidence of heart failure in the United States is increasing, which makes research even more important.
“We have a growing need for improved treatment options,” Dr. Grodin says. “Heart transplants are great, but we’re limited by the number of organs available. There are going to be more people needing better medical therapies, better LVADs, and other alternatives to transplants.”
Dr. Grodin joined the UT Southwestern faculty in 2016. In addition to treating patients with heart failure, he also cares for patients with cardiomyopathies and has significant experience with hypertrophic obstructive and nonobstructive cardiomyopathy.
No matter what heart issue he’s treating, Dr. Grodin says the best outcomes start with a meticulous, patient-centered approach to treatment.
“Sometimes heart failure is as bad as it sounds, but sometimes it might not be. When someone is frightened and you can offer reassurance, when someone is critically ill and you can offer a life-saving therapy, it’s incredibly gratifying.”
Results: 2 Locations